期刊文献+

高效液相色谱法测定盐酸加替沙星的含量

DETERMINATION OF GATIFLOXACIN IN GATIFLOXACIN HYDROCHLORIDE TABLETS BY HPLC
下载PDF
导出
摘要 目的建立高效液相色谱法测定盐酸加替沙星片中加替沙星的含量。方法采用钻石C18色谱柱(250 mm×4.6 mm,5μm),以乙腈-0.01 mol/L磷酸溶液(20:80)(用三乙胺调节pH至3.0)为流动相,检测波长为293 nm,流速为1.0 mL/min。结果加替沙星的浓度在10~120 μg/mL范围内与峰面积呈良好的线性关系.r=0.999 9。平均回收率为99.7%,相对标准差为1.29%(n=9)。结论本方法简便、准确、灵敏度高、专属性强、重现性好,可用于盐酸加替沙星片的质量控制。 Objective To establish a method for the determination of gatifloxacin in gatifloxacin hydrochloride tablets by high performance liquid chromatography (HPLC). Methods The analysis was carried on with diamonsil C18 column(250 mm× 4.6 mm, 5 /,m). The mobile phase was composed of acetonitrile 0.01 mol/L phosphoric acid solution (20:80) (adjusting the pH to 3.0 with triethylaemine). Detection wavelength was 293 nm and the flow rate was 1.0 mL/min. Results The calibration curve was linear between 10- 120μg/mL, r = 0.9999. The average recovery and RSD for gatifloxacin were 99.7% and 1.29% (n = 9) respectively. Conclusion This method is simple, accurate, sensitive, specific, reproducible, and suitable for the quality control of gatifloxacin hydrochloride tablets.
出处 《河北医科大学学报》 CAS 2009年第5期495-497,共3页 Journal of Hebei Medical University
关键词 色谱法 高压液相 盐酸加替沙星 质量控制 chromatography, high pressure liquid gatifloxacin hydrochloride quality control
  • 相关文献

参考文献3

二级参考文献26

  • 1[1]Hosaka M,Yaxue T, Fukuda H, Tomizawa H, et al.In vitro and in vivo antibacterial activities of AM-1 155, a new 6-fluoro-8-methoxy quinolone. Antimicrobial Agents Chemotherapy, 1992;36:2108~2117.
  • 2[2]Wakabayashi E, Mitsuhashi S. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methyoxy quinolone. Antimicrobial Agents Chemotherapy, 1994;38:594~601.
  • 3[3]Wise R, Brenwald NP, Andrews JM,et al. The activity of the methylpiperazinyl fluoroquinolone CG5501:A comparison with other fluoroquinolones fluoroquinolones. Antimicrobial Chemotherapy, 1997;39:447~452.
  • 4[4]National Committee for Clinical Laboratory Standards. 1998;18.
  • 5[5]Hosaka M,Kinoshita S, Toyama A,et al. Antibacterial Properties of AM-1155, a new 8-methoxy quinolone. Antimicrobial Chemotherapy, 1995; 36:293~301.
  • 6[6]Tanaka M,Takahashi K, Saika T, et al. Development of fluoroquinoloneresistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae in Japan. Urology, 1998; 159:2215~2219.
  • 7[7]Deguchi T, Yasuda M, Nakano M,ea al. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GryA and ParC.Chemotherapy, 1997;43:239~244.
  • 8[8]Nakashima M,Uematsu T,Kosuge K, et al. Single and multiple-dose pharmacolinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrobial Agents Chemotherapy,1995;39:2635~2640.
  • 9Masaki H, Tokutaro Y, Hideyuki F, et al. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone [J]. Antimicrob Agents Chemother,1992;36:2108
  • 10Barruga G, Alarcon N, Rojas L C. In vitro activity of gatifloxacin and 18 other antibiotics against respiratory tract pathogens. Program and abstracts of the 39th interscience conference on antimicrobial agents and chemotherapy [C].San Francisco, September 26-29,1999

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部